www.youtube.com – WJTV 12 News – 2023-07-07 18:11:54

SUMMARY: A new FDA-approved Alzheimer's drug called Lecanemab is offering new hope for those living with the disease in Mississippi. The drug has been shown to slow the progression of Alzheimer's, but it requires patients to come to an infusion center every two weeks for treatment. Dr. Juebin Huang, a neurology professor at the University of Mississippi Medical Center, has expressed excitement about the progress being made. However, there are risks associated with the drug, such as brain swelling or bleeding. While the drug's annual cost of $26,000 may be a barrier for some patients, doctors are hopeful that it will be covered by Medicare and Medicaid. Although there is no cure for Alzheimer's, this drug provides potential benefits for patients.

News.

Source